{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:13:50Z","timestamp":1769559230407,"version":"3.49.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["1R01DA040636-01"],"award-info":[{"award-number":["1R01DA040636-01"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["contemporaryclinicaltrials.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.cct.2016.12.015","type":"journal-article","created":{"date-parts":[[2016,12,20]],"date-time":"2016-12-20T17:01:41Z","timestamp":1482253301000},"page":"130-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Extended-release naltrexone for pre-release prisoners: A randomized trial of medical mobile treatment"],"prefix":"10.1016","volume":"53","author":[{"given":"Michael S.","family":"Gordon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank J.","family":"Vocci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terrence T.","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin E.","family":"O'Grady","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles P.","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cct.2016.12.015_bb0005","series-title":"Prisons And Drugs: A Global Review Of Incarceration, Drug Use And Drug Services","volume":"12","author":"Dolan","year":"2007"},{"issue":"2","key":"10.1016\/j.cct.2016.12.015_bb0010","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1360-0443.2006.01316.x","article-title":"Substance abuse and dependence in prisoners: A systematic review","volume":"101","author":"Fazel","year":"2006","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.cct.2016.12.015_bb0015","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/YCO.0b013e3282fc985c","article-title":"Drug use and health among prison inmates","volume":"21","author":"Kanato","year":"2008","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.cct.2016.12.015_bb0020","series-title":"Opioid Substitution Treatment in Custodial Settings. A Practical Guide","author":"Kastelic","year":"2008"},{"key":"10.1016\/j.cct.2016.12.015_bb0025","series-title":"Lowinson & Ruiz's Substance Abuse: A Comprehensive Textbook","first-page":"881","article-title":"Incarcerated populations","author":"Kinlock","year":"2011"},{"key":"10.1016\/j.cct.2016.12.015_bb0030","series-title":"Prisoners in 2012: Advance Counts","author":"Carson","year":"2013"},{"key":"10.1016\/j.cct.2016.12.015_bb0035","series-title":"Drug Use and Dependence, State and Federal Prisoners, 2004","author":"Mumola","year":"2006"},{"key":"10.1016\/j.cct.2016.12.015_bb0040","series-title":"Pharmacotherapy For Incarcerated Individuals With Histories Of Heroin Addiction","author":"Kinlock","year":"2007"},{"issue":"1","key":"10.1016\/j.cct.2016.12.015_bb0045","article-title":"Opioid addiction and criminal justice systems: Opportunities to break the cycle of incarceration. SGIM","volume":"38","author":"Fox","year":"2015","journal-title":"Forum"},{"issue":"3","key":"10.1016\/j.cct.2016.12.015_bb0050","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jsat.2006.12.019","article-title":"Drug treatment services for adult offenders: The state of the state","volume":"32","author":"Taxman","year":"2007","journal-title":"J. Subst. Abus. Treat."},{"issue":"8","key":"10.1016\/j.cct.2016.12.015_bb0055","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1111\/j.1360-0443.2006.01475.x","article-title":"Persistence of drug use during imprisonment: Relationship of drug type, recency of use and severity of dependence to use of heroin, cocaine and amphetamine in prison","volume":"101","author":"Strang","year":"2006","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.cct.2016.12.015_bb0060","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJMsa064115","article-title":"Release from prison\u2013a high risk of death for former inmates","volume":"356","author":"Binswanger","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.cct.2016.12.015_bb0065","doi-asserted-by":"crossref","first-page":"476","DOI":"10.2105\/AJPH.2008.149591","article-title":"Gender differences in chronic medical, psychiatric, and substance-dependence disorders among jail inmates","volume":"100","author":"Binswanger","year":"2010","journal-title":"Am. J. Public Health"},{"issue":"1","key":"10.1016\/j.cct.2016.12.015_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2010.11.029","article-title":"Risk factors for all-cause, overdose and early deaths after release from prison in Washington state","volume":"117","author":"Binswanger","year":"2011","journal-title":"Drug Alcohol Depend."},{"issue":"2","key":"10.1016\/j.cct.2016.12.015_bb0075","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1046\/j.1360-0443.2003.00264.x","article-title":"Male drugs-related deaths in the fortnight after release from prison: Scotland, 1996\u201399","volume":"98","author":"Bird","year":"2003","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.cct.2016.12.015_bb0080","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1360-0443.2007.02081.x","article-title":"Acute risk of drug-related death among newly released prisoners in England and Wales","volume":"103","author":"Farrell","year":"2008","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.cct.2016.12.015_bb0085","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/PAF.0b013e3181873784","article-title":"Drugs, detention, and death: A study of the mortality of recently released prisoners","volume":"30","author":"Krinsky","year":"2009","journal-title":"Am. J. Forensic Med. Pathol."},{"issue":"9","key":"10.1016\/j.cct.2016.12.015_bb0090","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1111\/j.1360-0443.2010.02990.x","article-title":"Meta-analysis of drug-related deaths soon after release from prison","volume":"105","author":"Merrall","year":"2010","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.cct.2016.12.015_bb0095","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1467-842X.2004.tb00629.x","article-title":"Risk of death in prisoners after release from jail","volume":"28","author":"Stewart","year":"2004","journal-title":"Aust. N. Z. J. Public Health"},{"key":"10.1016\/j.cct.2016.12.015_bb0100","series-title":"The War on Drugs IV: the Continuing Saga of the Mysteries and Miseries of Intoxication, Addiction, Crime and Public Policy","author":"Inciardi","year":"2008"},{"issue":"8\u201310","key":"10.1016\/j.cct.2016.12.015_bb0105","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1081\/JA-120004162","article-title":"Drug user treatment within a criminal justice context","volume":"37","author":"Hough","year":"2002","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.cct.2016.12.015_bb0110","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1177\/0032885503256325","article-title":"The effects of drug treatment on institutional behavior","volume":"83","author":"Kinlock","year":"2003","journal-title":"Prison J."},{"issue":"6","key":"10.1016\/j.cct.2016.12.015_bb0115","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/j.1360-0443.2005.01050.x","article-title":"Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration and hepatitis C infection","volume":"100","author":"Dolan","year":"2005","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.cct.2016.12.015_bb0120","first-page":"5","article-title":"Evaluation of opioid-dependent prisoners in oral opioid maintenance therapy","volume":"12","author":"Metz","year":"2010","journal-title":"Heroin Addict. Relat. Clin. Probl."},{"issue":"1","key":"10.1016\/j.cct.2016.12.015_bb0125","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0376-8716(03)00187-X","article-title":"Randomised controlled trial of methadone maintenance treatment versus wait list control in an Australian prison system","volume":"72","author":"Dolan","year":"2003","journal-title":"Drug Alcohol Depend."},{"issue":"3","key":"10.1016\/j.cct.2016.12.015_bb0130","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1360-0443.2011.03676.x","article-title":"The effectiveness of opioid maintenance treatment in prison settings: a systematic review","volume":"107","author":"Hedrich","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.cct.2016.12.015_bb0135","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/002204269302300106","article-title":"The effectiveness of in-jail methadone maintenance","volume":"23","author":"Magura","year":"1993","journal-title":"J. Drug Issues"},{"issue":"1\u20133","key":"10.1016\/j.cct.2016.12.015_bb0140","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.drugalcdep.2008.08.006","article-title":"Buprenorphine and methadone maintenance in jail and post-release: a randomized clinical trial","volume":"99","author":"Magura","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.cct.2016.12.015_bb0145","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1477-7517-7-17","article-title":"Drug use and opioid substitution treatment for prisoners","volume":"7","author":"Stover","year":"2010","journal-title":"Harm Reduct J."},{"issue":"1","key":"10.1016\/j.cct.2016.12.015_bb0150","first-page":"14","article-title":"The Key Extended Entry Program (KEEP): a methadone treatment program for opiate-dependent inmates","volume":"68","author":"Tomasino","year":"2001","journal-title":"Mt Sinai J. Med."},{"issue":"25","key":"10.1016\/j.cct.2016.12.015_bb0155","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1056\/NEJM196906192802502","article-title":"Methadone treatment of randomly selected criminal addicts","volume":"280","author":"Dole","year":"1969","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.cct.2016.12.015_bb0160","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/j.1360-0443.2008.002238.x","article-title":"Randomized clinical trial of methadone maintenance for prisoners: findings at 6months post-release","volume":"103","author":"Gordon","year":"2008","journal-title":"Addiction"},{"issue":"2\u20133","key":"10.1016\/j.cct.2016.12.015_bb0165","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.drugalcdep.2007.05.022","article-title":"Randomized clinical trial of methadone maintenance for prisoners: results at 1-month post-release","volume":"91","author":"Kinlock","year":"2007","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"10.1016\/j.cct.2016.12.015_bb0170","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/0093854807309111","article-title":"Study of methadone maintenance for male prisoners: 3-month postrelease outcomes","volume":"35","author":"Kinlock","year":"2008","journal-title":"Crim. Justice behav."},{"key":"10.1016\/j.cct.2016.12.015_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10509670802572243","article-title":"Treatment retention and changes in motivation among drug court probationers","volume":"48","author":"Kinlock","year":"2009","journal-title":"J. Offender Rehabil."},{"issue":"1","key":"10.1016\/j.cct.2016.12.015_bb0180","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/08897077.2011.611460","article-title":"Medication-assisted treatment in criminal justice agencies affiliated with the criminal justice-drug abuse treatment studies (CJ-DATS): availability, barriers, and intentions","volume":"33","author":"Friedmann","year":"2012","journal-title":"Subst. Abus."},{"issue":"1\u20132","key":"10.1016\/j.cct.2016.12.015_bb0185","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.drugalcdep.2009.06.015","article-title":"Methadone and buprenorphine prescribing and referral practices in US prison systems: results from a nationwide survey","volume":"105","author":"Nunn","year":"2009","journal-title":"Drug Alcohol Depend."},{"issue":"3","key":"10.1016\/j.cct.2016.12.015_bb0190","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/jurban\/jti072","article-title":"Attitudes and practices regarding the use of methadone in US state and federal prisons","volume":"82","author":"Rich","year":"2005","journal-title":"J Urban Health"},{"issue":"3","key":"10.1016\/j.cct.2016.12.015_bb0195","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1300\/J069v24n03_04","article-title":"Linkage with methadone treatment upon release from incarceration: a promising opportunity","volume":"24","author":"Rich","year":"2005","journal-title":"J. Addict. Dis."},{"issue":"2","key":"10.1016\/j.cct.2016.12.015_bb0200","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jsat.2013.02.005","article-title":"Initiation of buprenorphine during incarceration and retention in treatment upon release","volume":"45","author":"Zaller","year":"2013","journal-title":"J. Subst. Abus. Treat."},{"issue":"1","key":"10.1016\/j.cct.2016.12.015_bb0205","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/10550887.2011.642757","article-title":"The emerging buprenorphine epidemic in the United States","volume":"31","author":"Wish","year":"2012","journal-title":"J. Addict. Dis."},{"issue":"1","key":"10.1016\/j.cct.2016.12.015_bb0210","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001333.pub2","article-title":"Oral naltrexone maintenance treatment for opioid dependence","author":"Minozzi","year":"2006","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.cct.2016.12.015_bb0215","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1300\/J069v19n01_06","article-title":"Improving naltrexone response: an intervention for medical practitioners to enhance medication compliance in alcohol dependent patients","volume":"19","author":"Pettinati","year":"2000","journal-title":"J. Addict. Dis."},{"issue":"1","key":"10.1016\/j.cct.2016.12.015_bb0220","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1080\/08897077.2011.609438","article-title":"A multisite pilot study of extended-release injectable naltrexone treatment for previously opioid-dependent parolees and probationers","volume":"33","author":"Coviello","year":"2012","journal-title":"Subst. Abus."},{"issue":"13","key":"10.1016\/j.cct.2016.12.015_bb0225","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1056\/NEJMoa1505409","article-title":"Extended-release naltrexone to prevent opioid relapse in criminal justice offenders","volume":"374","author":"Lee","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cct.2016.12.015_bb0230","series-title":"Six-Month Depot Naltrexone Treatment Reduces Relapse in Parolees Formerly Addicted to Opioids. Poster presented at 51st Annual Meeting of the American College of Neuropsychopharmacology; December 2\u20136, 2012","author":"Cornish","year":"2012"},{"issue":"6","key":"10.1016\/j.cct.2016.12.015_bb0235","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/add.12894","article-title":"Opioid treatment at release from jail using extended-release naltrexone: a pilot proof-of-concept randomized effectiveness trial","volume":"110","author":"Lee","year":"2015","journal-title":"Addiction"},{"issue":"5","key":"10.1016\/j.cct.2016.12.015_bb0240","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s11920-010-0135-5","article-title":"Use of naltrexone to treat opioid addiction in a country in which methadone and buprenorphine are not available","volume":"12","author":"Krupitsky","year":"2010","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.cct.2016.12.015_bb0245","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jsat.2015.07.005","article-title":"Phase 4, pilot, open-label study of VIVITROL(R) (extended-release naltrexone XR-NTX) for prisoners","volume":"59","author":"Gordon","year":"2015","journal-title":"J. Subst. Abus. Treat."},{"issue":"1","key":"10.1016\/j.cct.2016.12.015_bb0250","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0740-5472(02)00343-4","article-title":"Feasibility of referring drug users from a needle exchange program into an addiction treatment program: experience with a mobile treatment van and LAAM maintenance","volume":"24","author":"Kuo","year":"2003","journal-title":"J. Subst. Abus. Treat."},{"issue":"10","key":"10.1016\/j.cct.2016.12.015_bb0255","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1111\/j.1360-0443.1990.tb01598.x","article-title":"The \u2018methadone by bus\u2019 project in Amsterdam","volume":"85","author":"Buning","year":"1990","journal-title":"Br. J. Addict."},{"issue":"2","key":"10.1016\/j.cct.2016.12.015_bb0260","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0376-8716(96)01273-2","article-title":"Patient retention in mobile and fixed-site methadone maintenance treatment","volume":"42","author":"Greenfield","year":"1996","journal-title":"Drug Alcohol Depend."},{"issue":"4","key":"10.1016\/j.cct.2016.12.015_bb0265","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jsat.2013.11.002","article-title":"Mobile opioid agonist treatment and public funding expands treatment for disenfranchised opioid-dependent individuals","volume":"46","author":"Hall","year":"2014","journal-title":"J. Subst. Abus. Treat."},{"issue":"12","key":"10.1016\/j.cct.2016.12.015_bb0270","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1089\/apc.1998.12.931","article-title":"Mobile HIV education and testing program: bringing services to hard-to-reach populations","volume":"12","author":"O'Connor","year":"1998","journal-title":"AIDS Patient Care STDs"},{"issue":"10","key":"10.1016\/j.cct.2016.12.015_bb0275","doi-asserted-by":"crossref","first-page":"788","DOI":"10.2471\/BLT.09.063982","article-title":"Expansion of antiretroviral treatment to rural health centre level by a mobile service in Mumbwa district, Zambia","volume":"88","author":"Dube","year":"2010","journal-title":"Bull. World Health Organ."},{"issue":"3","key":"10.1016\/j.cct.2016.12.015_bb0280","doi-asserted-by":"crossref","first-page":"293","DOI":"10.5172\/jamh.2012.10.3.292","article-title":"There a difference? A comparative study of mobile intensive treatment team and continuing care team consumers' clinical and other characteristics","volume":"10","author":"Suggett","year":"2012","journal-title":"Adv. Ment. Health"},{"issue":"2","key":"10.1016\/j.cct.2016.12.015_bb0285","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1365-2354.2008.01007.x","article-title":"Who visits mobile UK services providing cancer information and support in the community?","volume":"19","author":"Foster","year":"2010","journal-title":"Eur. J. Cancer Care (Engl)."},{"issue":"4","key":"10.1016\/j.cct.2016.12.015_bb0290","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1365-2354.2011.01247.x","article-title":"Patient perceptions of a mobile cancer support unit in South Wales","volume":"20","author":"Iredale","year":"2011","journal-title":"Eur. J. Cancer Care (Engl)."},{"issue":"4","key":"10.1016\/j.cct.2016.12.015_bb0295","doi-asserted-by":"crossref","first-page":"219","DOI":"10.5055\/jom.2009.0024","article-title":"Overcoming obstacles to implementing methadone maintenance therapy for prisoners: implications for policy and practice","volume":"5","author":"McKenzie","year":"2009","journal-title":"J. Opioid Manag."},{"key":"10.1016\/j.cct.2016.12.015_bb0300","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.drugalcdep.2014.05.011","article-title":"Randomized controlled trial of prison-initiated buprenorphine: prison outcomes and community treatment entry","volume":"142","author":"Gordon","year":"2014","journal-title":"Drug Alcohol Depend."},{"issue":"3","key":"10.1016\/j.cct.2016.12.015_bb0305","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0740-5472(92)90062-S","article-title":"The fifth edition of the addiction severity index","volume":"9","author":"McLellan","year":"1992","journal-title":"J. Subst. Abus. Treat."},{"issue":"1","key":"10.1016\/j.cct.2016.12.015_bb0310","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00005053-198001000-00006","article-title":"An improved diagnostic evaluation instrument for substance abuse patients. The addiction severity index","volume":"168","author":"McLellan","year":"1980","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.cct.2016.12.015_bb0315","series-title":"International Conference on AIDS. Measuring Risk Behavior among IDUs: validation of the Risk for AIDS Behavior (RAB) Scale. Paper presented at: Int Conf AIDS; Jul 19\u201324, 1992","author":"Metzger","year":"1992"},{"issue":"4","key":"10.1016\/j.cct.2016.12.015_bb0320","doi-asserted-by":"crossref","first-page":"267","DOI":"10.15288\/jsa.1985.46.267","article-title":"Reactivity to alcohol-related cues: physiological and subjective responses in alcoholics and nonproblem drinkers","volume":"46","author":"Kaplan","year":"1985","journal-title":"J. Stud. Alcohol"},{"issue":"3","key":"10.1016\/j.cct.2016.12.015_bb0325","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0740-5472(86)90018-8","article-title":"Conditioned responses in a methadone population. A comparison of laboratory, clinic, and natural settings","volume":"3","author":"Childress","year":"1986","journal-title":"J. Subst. Abus. Treat."},{"issue":"3","key":"10.1016\/j.cct.2016.12.015_bb0330","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.drugalcdep.2009.03.007","article-title":"Interim methadone treatment: impact on arrests","volume":"103","author":"Schwartz","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.cct.2016.12.015_bb0335","series-title":"Statistical Power Analysis For The Behavioral Sciences","author":"Cohen","year":"1988"},{"issue":"6","key":"10.1016\/j.cct.2016.12.015_bb0340","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/bsl.1015","article-title":"Medication-assisted treatment research with criminal justice populations: challenges of implementation","volume":"29","author":"Gordon","year":"2011","journal-title":"Behav. Sci. Law"}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714416302300?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714416302300?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T19:41:20Z","timestamp":1568662880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714416302300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":68,"alternative-id":["S1551714416302300"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2016.12.015","relation":{},"ISSN":["1551-7144"],"issn-type":[{"value":"1551-7144","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extended-release naltrexone for pre-release prisoners: A randomized trial of medical mobile treatment","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cct.2016.12.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}